Cargando…

Upregulation of SMYD3 and SMYD3 VNTR 3/3 polymorphism increase the risk of hepatocellular carcinoma

SMYD3 (SET and MYND domain-containing protein 3) is involved in histone modification, which initiates oncogenesis by activating transcription of multiple downstream genes. To investigate associations of variable numbers of tandem repeats (VNTR) variants in the SMYD3 gene promoter, SMYD3 serum levels...

Descripción completa

Detalles Bibliográficos
Autores principales:	Binh, Mai Thanh, Hoan, Nghiem Xuan, Giang, Dao Phuong, Tong, Hoang Van, Bock, C.-Thomas, Wedemeyer, Heiner, Toan, Nguyen Linh, Bang, Mai Hong, Kremsner, Peter G., Meyer, Christian G., Song, Le Huu, Velavan, Thirumalaisamy P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7029004/ https://www.ncbi.nlm.nih.gov/pubmed/32071406 http://dx.doi.org/10.1038/s41598-020-59667-z

Ejemplares similares

SOCS3 genetic variants and promoter hypermethylation in patients with chronic hepatitis B
por: Hoan, Nghiem Xuan, et al.
Publicado: (2017)

HDV infection rates in northern Vietnam
por: Binh, Mai Thanh, et al.
Publicado: (2018)

Vitamin D receptor ApaI polymorphism associated with progression of liver disease in Vietnamese patients chronically infected with hepatitis B virus
por: Hoan, Nghiem Xuan, et al.
Publicado: (2019)

Interferon-stimulated gene 15 in hepatitis B-related liver diseases
por: Hoan, Nghiem Xuan, et al.
Publicado: (2016)

Interferon-stimulated gene 20 kDa protein serum levels and clinical outcome of hepatitis B virus-related liver diseases
por: Van Tong, Hoang, et al.
Publicado: (2018)

Association of vitamin D deficiency with hepatitis B virus - related liver diseases
por: Hoan, Nghiem Xuan, et al.
Publicado: (2016)

Viral and serological testing of SARS-CoV-2 among health care workers and patients in Vietnam
por: Song, Le Huu, et al.
Publicado: (2021)

Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression
por: Hoan, Nghiem Xuan, et al.
Publicado: (2021)

Author Correction: Genetic variants of programmed cell death 1 are associated with HBV infection and liver disease progression
por: Hoan, Nghiem Xuan, et al.
Publicado: (2022)

Predominance of HBV Genotype B and HDV Genotype 1 in Vietnamese Patients with Chronic Hepatitis
por: Hoan, Nghiem Xuan, et al.
Publicado: (2021)

Custom gene expression panel for evaluation of potential molecular markers in hepatocellular carcinoma
por: Pallerla, Srinivas Reddy, et al.
Publicado: (2022)

High Hepatitis E virus (HEV) Positivity Among Domestic Pigs and Risk of HEV Infection of Individuals Occupationally Exposed to Pigs and Pork Meat in Hanoi, Vietnam
por: Hoan, Nghiem Xuan, et al.
Publicado: (2019)

Rapid, low cost and sensitive detection of Calreticulin mutations by a PCR based amplicon length differentiation assay for diagnosis of myeloproliferative neoplasms
por: Trung, Ngo Tat, et al.
Publicado: (2019)

Smyd3 Is Required for the Development of Cardiac and Skeletal Muscle in Zebrafish
por: Fujii, Tomoaki, et al.
Publicado: (2011)

Structural and Functional Profiling of the Human Histone Methyltransferase SMYD3
por: Foreman, Kenneth W., et al.
Publicado: (2011)

SMYD3 promotes the epithelial–mesenchymal transition in breast cancer
por: Fenizia, Claudio, et al.
Publicado: (2019)

SMYD3: a regulator of epigenetic and signaling pathways in cancer
por: Bernard, Benjamin J., et al.
Publicado: (2021)

EZH2 and SMYD3 expression in papillary thyroid cancer
por: Sawicka-Gutaj, Nadia, et al.
Publicado: (2021)

Identifying novel SMYD3 interactors on the trail of cancer hallmarks
por: Fasano, Candida, et al.
Publicado: (2022)

Small molecule inhibitors and CRISPR/Cas9 mutagenesis demonstrate that SMYD2 and SMYD3 activity are dispensable for autonomous cancer cell proliferation
por: Thomenius, Michael J., et al.
Publicado: (2018)

New open conformation of SMYD3 implicates conformational selection and allostery
por: Spellmon, Nicholas, et al.
Publicado: (2016)

Histone methyltransferase Smyd3 is a new regulator for vascular senescence
por: Yang, Di, et al.
Publicado: (2020)

SMYD3: An Oncogenic Driver Targeting Epigenetic Regulation and Signaling Pathways
por: Bottino, Cinzia, et al.
Publicado: (2020)

The SMYD3 methyltransferase promotes myogenesis by activating the myogenin regulatory network
por: Codato, Roberta, et al.
Publicado: (2019)

The Lysine Methylase SMYD3 Modulates Mesendodermal Commitment during Development
por: Fittipaldi, Raffaella, et al.
Publicado: (2021)

Discovery of an Allosteric Ligand Binding Site in SMYD3 Lysine Methyltransferase
por: Talibov, Vladimir O., et al.
Publicado: (2021)

SMYD3 Modulates the HGF/MET Signaling Pathway in Gastric Cancer
por: De Marco, Katia, et al.
Publicado: (2023)

Upregulation of Enzymes involved in ISGylation and Ubiquitination in patients with hepatocellular carcinoma
por: Tong, Hoang Van, et al.
Publicado: (2020)

SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancer
por: Mazur, Pawel K., et al.
Publicado: (2014)

Effect of SMYD3 on biological behavior and H3K4 methylation in bladder cancer
por: Wu, Xiang, et al.
Publicado: (2019)

STAT3 promotes chronic lymphocytic leukemia progression through upregulating SMYD3 expression
por: Ma, Wei, et al.
Publicado: (2018)

Soluble fibrinogen-like protein 2 levels in patients with hepatitis B virus-related liver diseases
por: Van Tong, Hoang, et al.
Publicado: (2018)

ANKHD1 is required for SMYD3 to promote tumor metastasis in hepatocellular carcinoma
por: Zhou, Zhenyu, et al.
Publicado: (2019)

Network analyses elucidate the role of SMYD3 in esophageal squamous cell carcinoma
por: Liu, Xinning, et al.
Publicado: (2017)

Cell geometry and the cytoskeleton impact the nucleo-cytoplasmic localisation of the SMYD3 methyltransferase
por: Pereira, David, et al.
Publicado: (2020)

Exploration of the Substrate Preference of Lysine Methyltransferase SMYD3 by Molecular Dynamics Simulations
por: Sun, Jixue, et al.
Publicado: (2019)

Anticancer Impact of Nitric Oxide (NO) and NO Combination with SMYD-3 Inhibitor on Breast Carcinomas
por: Gordon, Jenna L., et al.
Publicado: (2021)

SMYD5 catalyzes histone H3 lysine 36 trimethylation at promoters
por: Zhang, Yanjun, et al.
Publicado: (2022)

The SMYD3-MAP3K2 signaling axis promotes tumor aggressiveness and metastasis in prostate cancer
por: Ikram, Sabeen, et al.
Publicado: (2023)

Hepatitis E Virus Mutations: Functional and Clinical Relevance
por: van Tong, Hoang, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ip19ipa6us20q62kd1lht48hbq